Shire's Lawsuit Against Nostrum Moves Forward After Judge Denies Motion
A federal judge in New Jersey has denied Nostrum Pharmaceuticals' motion for summary judgment in Shire Pharmaceuticals Group's patent infringement lawsuit over Nostrum's plans to make a generic version of the...To view the full article, register now.
Already a subscriber? Click here to view full article